On November 12th, PW MEDTECH (01358) spent 1.034 million Hong Kong dollars to repurchase 1 million shares.
PwC Holdings Limited (01358) announced on November 12, 2024 that it will spend HK$103.4 million to repurchase its shares.
PW MEDTECH (01358) announced that on November 12, 2024, it will spend 1.034 million Hong Kong dollars to repurchase 1 million shares at a repurchase price of 1.03-1.04 Hong Kong dollars per share.
Related Articles

TRAD CHI MED (00570) released its annual performance report, with a net loss of 458 million RMB, compared to a profit in the same period last year.

XXF(02473): Mai Baowen appointed as Company Secretary.

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced its annual performance, with a net profit attributable to shareholders of 2.983 billion yuan, an increase of 5.21% year-on-year.
TRAD CHI MED (00570) released its annual performance report, with a net loss of 458 million RMB, compared to a profit in the same period last year.

XXF(02473): Mai Baowen appointed as Company Secretary.

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced its annual performance, with a net profit attributable to shareholders of 2.983 billion yuan, an increase of 5.21% year-on-year.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


